Quarterly report pursuant to Section 13 or 15(d)

Document Entity Information

v3.21.2
Document Entity Information - shares
9 Months Ended
Mar. 31, 2021
Jun. 16, 2021
Cover [Abstract]    
Entity Registrant Name Anebulo Pharmaceuticals, Inc.  
Entity Central Index Key 0001815974  
Document Type 10-Q  
Document Period End Date Mar. 31, 2021  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Entity Current Reporting Status No  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business Flag true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   23,344,567
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2020